With A 38% Price Drop For Oscotec Inc. (KOSDAQ:039200) You'll Still Get What You Pay For
Nov 20
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Pharma Industry Analysis
UpdatedNov 21, 2024
DataAggregated Company Financials
Companies102
- 7D-3.0%
- 3M-7.0%
- 1Y6.3%
- YTD-6.8%
Over the last 7 days, the Pharma industry has dropped 6.3%, driven by declines in Yuhan and SK Biopharmaceuticals of 5.4% and 6.0%, respectively. In contrast, Caregen has gained 12%. This takes the industry's 12 month performance to a gain of 5.5%. Earnings are forecast to grow by 33% annually.
Industry Valuation and Performance
Has the South Korean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | ₩52.3t | ₩28.9t | ₩876.4b | 15x | 59.6x | 1.8x |
| Sat, 19 Oct 2024 | ₩63.5t | ₩28.7t | ₩833.2b | 15.8x | 76.2x | 2.2x |
| Mon, 16 Sep 2024 | ₩57.2t | ₩28.8t | ₩836.8b | 15.1x | 68.4x | 2x |
| Wed, 14 Aug 2024 | ₩53.8t | ₩28.5t | ₩768.0b | 14.7x | 70.1x | 1.9x |
| Fri, 12 Jul 2024 | ₩54.8t | ₩28.4t | ₩762.2b | 13.8x | 71.9x | 1.9x |
| Sun, 09 Jun 2024 | ₩54.5t | ₩30.2t | ₩909.1b | 13.4x | 60x | 1.8x |
| Tue, 07 May 2024 | ₩53.9t | ₩29.7t | ₩942.4b | 17.4x | 57.2x | 1.8x |
| Thu, 04 Apr 2024 | ₩52.8t | ₩29.4t | ₩922.9b | 17.7x | 57.2x | 1.8x |
| Sat, 02 Mar 2024 | ₩52.8t | ₩29.6t | ₩593.1b | 20.3x | 89.1x | 1.8x |
| Mon, 29 Jan 2024 | ₩51.7t | ₩29.6t | ₩592.3b | 22.6x | 87.3x | 1.7x |
| Wed, 27 Dec 2023 | ₩52.7t | ₩29.6t | ₩588.2b | 22.4x | 89.5x | 1.8x |
| Fri, 24 Nov 2023 | ₩50.3t | ₩29.4t | ₩640.9b | 19.6x | 78.5x | 1.7x |
| Sun, 22 Oct 2023 | ₩45.1t | ₩29.3t | ₩683.3b | 15.5x | 66x | 1.5x |
| Tue, 19 Sep 2023 | ₩52.7t | ₩29.3t | ₩683.3b | 17.2x | 77.2x | 1.8x |
| Thu, 17 Aug 2023 | ₩52.1t | ₩28.8t | ₩901.2b | 23.2x | 57.8x | 1.8x |
| Sat, 15 Jul 2023 | ₩46.8t | ₩28.8t | ₩899.2b | 21x | 52x | 1.6x |
| Mon, 12 Jun 2023 | ₩48.1t | ₩28.9t | ₩908.3b | 22.6x | 53x | 1.7x |
| Wed, 10 May 2023 | ₩48.4t | ₩28.5t | ₩602.7b | 21.4x | 80.4x | 1.7x |
| Fri, 07 Apr 2023 | ₩47.0t | ₩28.5t | ₩602.8b | 19.5x | 78x | 1.7x |
| Sun, 05 Mar 2023 | ₩44.6t | ₩27.7t | ₩743.5b | 20.5x | 59.9x | 1.6x |
| Tue, 31 Jan 2023 | ₩45.1t | ₩27.7t | ₩743.5b | 19.7x | 60.6x | 1.6x |
| Thu, 29 Dec 2022 | ₩46.8t | ₩28.0t | ₩770.2b | 20.7x | 60.8x | 1.7x |
| Sat, 26 Nov 2022 | ₩44.5t | ₩27.7t | ₩723.8b | 18.1x | 61.5x | 1.6x |
| Mon, 24 Oct 2022 | ₩40.9t | ₩27.2t | ₩694.8b | 20.2x | 58.8x | 1.5x |
| Wed, 21 Sep 2022 | ₩46.0t | ₩27.5t | ₩720.9b | 20.9x | 63.9x | 1.7x |
| Fri, 19 Aug 2022 | ₩51.2t | ₩26.7t | ₩476.4b | 22.8x | 107.4x | 1.9x |
| Sun, 17 Jul 2022 | ₩50.7t | ₩26.7t | ₩475.9b | 21.7x | 106.5x | 1.9x |
| Tue, 14 Jun 2022 | ₩49.6t | ₩26.7t | ₩475.9b | 22.4x | 104.2x | 1.9x |
| Thu, 12 May 2022 | ₩52.9t | ₩26.1t | ₩674.7b | 25.5x | 78.5x | 2x |
| Sat, 09 Apr 2022 | ₩56.1t | ₩26.1t | ₩674.4b | 26.4x | 83.2x | 2.2x |
| Mon, 07 Mar 2022 | ₩55.2t | ₩25.0t | ₩934.5b | 24.1x | 59.1x | 2.2x |
| Wed, 02 Feb 2022 | ₩50.9t | ₩25.0t | ₩934.5b | 21.3x | 54.5x | 2x |
| Fri, 31 Dec 2021 | ₩60.9t | ₩25.0t | ₩934.5b | 24.9x | 65.2x | 2.4x |
| Sun, 28 Nov 2021 | ₩58.7t | ₩24.9t | ₩866.3b | 26.8x | 67.8x | 2.4x |
Price to Earnings Ratio
67.8x
Current Industry PE
- Investors are pessimistic on the South Korean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 61.2x which is lower than its 3-year average PE of 70.9x.
- The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 5.0% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | 2.33% | |
| Healthcare | -1.15% | |
| Pharma | -3.01% | |
| Pharma | -3.01% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A214370 Caregen | ₩23.15k | 23.5% +₩216.2b | -16.1% | PE31.8x | |
| A000250 Sam Chun Dang Pharm | ₩113.30k | 4.5% +₩114.0b | 63.0% | PS12.9x | |
| A068760 Celltrion Pharm | ₩55.60k | 3.9% +₩87.0b | -35.3% | n/a | |
| A047920 HLB Pharmaceutical | ₩21.80k | 27.1% +₩65.3b | 75.0% | n/a | |
| A200670 Humedix | ₩30.65k | 20.0% +₩53.0b | -11.4% | n/a |
